Deep River, CT, United States of America

Erin M Duffy

This inventor holds 23 USPTO granted patents and 10 published patent applications and 5 EPO patents, primarily in Antimicrobial Research. Top assignees: Bioversys Ag, Melinta Therapeutics, Inc., Melinta Subsidiary Corp.. Active years: 2004-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erin M Duffy. Retrieved from https://idiyas.com/inventor/erin-m-duffy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 23 (Patent Applications = 10)

% Patents Active = 69.6

EPO Patents = 5 (Patent Applications = 13)

Average Co-Inventor Count = 3.5

ph-index = 7

Forward Citations = 104(Granted Patents)

Location History:

New Haven, CT (US) (2018)
Deep River, CT (US) (2004 - 2024)

Company Filing History:

Melinta Therapeutics, Inc.

patents

2 out of 15

Melinta Subsidiary Corp.

patents

4. 2 out of 17

Rib-X Pharmaceuticals, Inc.

patents

5. 1 out of 1

Melinta Subsidary Corp.

Years Active: 2004-2026

Loading Chart...

Areas of Expertise:

Antimicrobial Compounds

Infection Treatment

Obesity

Biodefense Agents

Pyrrolo[2,3-d]pyrimidines

Bifunctional Heterocyclic Compounds

Chemokine Receptor Modulators

Antibiotics

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12558349 - Methods of treating infections in overweight and obese patients using antibiotics (2026-02-24),

2. 12297201 - Substituted pyrrolo[2,3-d]pyrimidines as antimicrobials (2025-05-13),

3. 12234238 - Antimicrobial compounds and methods of making and using the same (2025-02-25),

4. 12152031 - Biodefense agents (2024-11-26),

5. 12036219 - Methods of treating infections in overweight and obese patients using antibiotics (2024-07-16),

6. 11999739 - Antimicrobials methods of making and using the same (2024-06-04),

7. 11098047 - Antimicrobials and methods of making and using same (2021-08-24),

8. 10947237 - Antimicrobial compounds and methods of making and using the same (2021-03-16),

9. 10934295 - Antimicrobials and methods of making and using same (2021-03-02),

10. 10815238 - Antimicrobial compounds and methods of making and using the same (2020-10-27),

11. 10815237 - Antimicrobials and methods of making and using same (2020-10-27),

12. 10471046 - Method for treating, preventing, or reducing the risk of skin infection (2019-11-12),

13. 10259825 - Antimicrobial compounds and methods of making and using the same (2019-04-16),

14. 10106543 - Antimicrobial compounds and methods of making and using the same (2018-10-23),

15. 9845297 - Antimicrobial compounds and methods of making and using the same (2017-12-19),

Title: A Spotlight on Erin M. Duffy: Innovator in Antimicrobial Solutions

Introduction

Erin M. Duffy, based in Deep River, Connecticut, is an accomplished inventor with a remarkable portfolio of 21 patents. His work primarily focuses on developing novel antimicrobial compounds and methods that address some of the most pressing health challenges related to microbial infections.

Latest Patents

Duffy’s latest patents revolve around two significant areas. The first involves antimicrobial compounds, wherein he discloses methods for creating and utilizing these compounds to treat, prevent, and reduce the risk of microbial infections in both humans and animals. Specifically, he presents a compound of Formula (I) designed to enhance the effectiveness of treatments against various microbial threats.

The second patent centers on biodefense agents, providing methods for addressing infections caused by microorganisms that could be used as biological weapons. This innovative approach involves administering a pyrrolocytosine compound or its tautomer, along with pharmaceutically acceptable salts, aimed at improving the safety and efficacy of treatments.

Career Highlights

Throughout his career, Duffy has made significant contributions while working at reputable companies such as Melinta Therapeutics, Inc. and Bioversys AG. His role in these organizations has facilitated advancements in the field of microbiology and pharmaceutical innovation.

Collaborations

Erin has collaborated with esteemed colleagues, including Ashoke Bhattacharjee and Zoltan F. Kanyo. Their joint efforts have resulted in impactful advancements in the research and development of antimicrobial strategies, further solidifying Duffy's reputation as a leader in this essential field.

Conclusion

In conclusion, Erin M. Duffy stands out as a dedicated innovator whose work is crucial in the fight against microbial infections. With his extensive patent portfolio and collaborative spirit, he continues to pave the way for future advancements in antimicrobial solutions, underscoring the vital importance of innovation in healthcare.

Profile summary based on public USPTO records.